Skip to main content
. 2018 Feb 26;170(1):35–43. doi: 10.1007/s10549-018-4730-1

Table 2.

Immunochemical data and molecular subtype features of the cohort (n = 1010)

Parameters Number (%)
ER positivity scorea
 0 340 (33.7)
 0–10% 31 (3.1)
 ≥10% 639 (63.2)
PR positivity scorea
 0 477 (47.2)
 0–10% 20 (2.0)
 ≥ 10% 513 (50.8)
Her-2
 Positive 356 (35.2)
 Negative 514 (50.9)
 Unknown 140 (13.9)
Ki67
 < 14% 295 (29.2)
 ≥ 14% 715 (70.8)
Molecular subtypeb
 Luminal 372 (36.8)
 Luminal/HER2 170 (16.8)
 HER2 186 (18.4)
 TN 142 (14.1)
 Unknown 140 (13.9)

ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2

aPositive ≥ 1%

bLuminal: HR+/HER2−, luminal/HER2: HR+/HER2+, HER2: HR−/HER2+, TN: HR−/HER2−